Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-906-2 | CAS number: 22450-96-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 08 May to 21 May 2013 experimental in-life
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP Guideline (OECD 429) compliant study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2014
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- Pooled treatment group approach
- Deviations:
- yes
- Remarks:
- chemical analysis of the formulated test substance was not performed
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 4,4'-dioxo-4H,4'H-2,2'-spirobi[[1,3,2]benzodioxaborinin]-2-uide; tributylazanium
- EC Number:
- 700-906-2
- Cas Number:
- 22450-96-0
- Molecular formula:
- C26H36BNO6
- IUPAC Name:
- 4,4'-dioxo-4H,4'H-2,2'-spirobi[[1,3,2]benzodioxaborinin]-2-uide; tributylazanium
- Reference substance name:
- SABoTBA
- IUPAC Name:
- SABoTBA
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- Tri-n-butylammonium borodisalicylate was received on 4 March 2013
- Name of test material (as cited in study report): SABoTBA
- Purity: 98.77%
- Purity test date: 08 April 2014
- Lot/batch No.: 12342
- Expiration date of the lot/batch: Stable under recommended storage conditions
- Storage condition of test material: Room temperature in the dark
Constituent 1
Constituent 2
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River UK.
- Age at study initiation: 8 - 12 weeks at start of treatment
- Weight at study initiation: 17.3 - 21.9 g
- Housing: in pairs
- Diet (e.g. ad libitum): Rat and Mouse No. 1 maintenance diet, Ad-libitum
- Water (e.g. ad libitum): potable water supplied in polycarbonate bottles fitted with sipper tubes, ad-libitum
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-23°C
- Humidity (%): 40 - 70%
- Air changes (per hr): monitored but actual number not included in the study report.
- Photoperiod (hrs dark / hrs light): 12 hours light / 12 hours dark
IN-LIFE DATES: From: To: 08 May to 20 May 2013
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 10, 25 and 50% w/v in the vehilce. Higher concentrations were not possible to formulate as the material was too bulky.
- No. of animals per dose:
- 4 in main study
- Details on study design:
- RANGE FINDING TESTS:
- Preliminary invstigations were performed on 2 animals/treatment and treated at 25 and 50% w/v SABoTBA.
- Compound solubility: NA, formulation was a suspension.
- Irritation: no erythema noted. No effect of treatment on ear thickness.
- Lymph node proliferation response: not performed.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: LLNA pooled treatemnt group approach
- Criteria used to consider a positive response: SI of 3 or greater.
MAIN STUDY
TREATMENT PREPARATION AND ADMINISTRATION
Formulations were freshly prepared on each day of treatment using acetone/olive oil. A positive control group was similarly treated with 25% v/v hexylcinnamic aldehyde in acetone: olive oil (4:1 v/v).
The test item was prepared for administration in the main study at 10, 25 and 50% v/v in acetone/olive oil. The mice were treated by daily application of 25 µL of the appropriate concentration of the test substance to the dorsal surface of each ear for three consecutive days (Days 1-3). The test
substance was applied to the dorsal surface of each ear using an automatic micropipette and was spread over the entire dorsal surface of the ear using the tip of the pipette. Further groups of four mice received the vehicle alone or the positive control substance in the same manner.
Five days following the first topical application of test substance (Day 6) all mice were injected via the tail vein with 250 μ/L of phosphate buffered saline containing 3H-methyl Thymidine (Tritiated 3H-methyl thymidine (3HTdR) at 80 μCi/mL was used in the study) giving a nominal 20 μ Ci to each mouse. The injection into the tail vein was carried out using a plastic syringe and needle after the mouse had been heated in a warming chamber. Five hours later the animals were euthanased by carbon dioxide asphyxiation and the draining auricular lymph nodes were recovered from each animal. The nodes from mice subjected to the same treatment were pooled and suspensions of the cellular components of the lymph nodes were prepared in 5% w/v trichloroacetic acid and processed through a scintillation counter.
Test results are expressed in terms of Stimulation Indices, the ratios of the mean scintillation count per group obtained from the test groups relative to the corresponding mean scintillation count from controls. The threshold level for the Stimulation Index to be considered a positive indicator of the potential to cause skin sensitisation is 3.0.
RECOVERY OF LYMPH NODES
Once death had been confirmed for each mouse the auricular lymph nodes were excised and pooled nodes of all mice from each dose group were placed in 1 mL phosphate buffered saline.
PREPARATION FOR SCINTILLATION COUNT
A single cell suspension of lymph node cells (LNC) was prepared by gentle mechanical disaggregation through a stainless steel gauze (200 mesh size). The pooled LNC were then washed by adding 10 mL PBS, pelleted at 190 x g for 10 minutes and resuspended. The cells were washed twice again and resuspended in 3 mL trichloroacetic acid (TCA: 5%) following the final wash.
SCINTILLATION COUNTING
After overnight incubation (minimum of 18 hours) with 5% TCA at 4°C, the precipitate was recovered by centrifugation and resuspended in 1 mL 5% TCA and transferred to 10 mL Ultima gold scintillation fluid on Day 7. The 3HTdR incorporation was measured by β-scintillation counting. The proliferative response of LNC was expressed as radioactive disintegrations per minute per lymph node (dpm/node).
Results for each treatment group were expressed as the Stimulation Index (SI). This was derived by dividing the mean dpm/mouse for each treated group and the positive control group by the mean dpm/mouse in the vehicle control group.
If the SI is 3 or more, the test substance is regarded as a skin sensitizer.
The positive control group is expected to give an SI of 3 or more to demonstrate the validity of the study.
The Estimated Concentration of Three (EC3) is the concentration of test substance which would result in a SI of 3 and, where data permits, this value was calculated (Ryan 2007). As all concentrations tested resulted in an SI of less than 3 then the EC3 was reported as greater than the highest concentration tested 50% w/v. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
- Positive control results:
- The SI for the positive control substance hexyl cinnamic aldehyde (HCA) was 5.6 which demonstrates the validity of this study.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 1.1
- Test group / Remarks:
- 10 % SABoTBA / 4 animals
- Key result
- Parameter:
- SI
- Value:
- 1
- Test group / Remarks:
- 25 % SABoTBA / 4 animals
- Key result
- Parameter:
- SI
- Value:
- 1.5
- Test group / Remarks:
- 50 % SABoTBA / 4 animals
Any other information on results incl. tables
Preliminary investigations were performed at 25 and 50% w/v with 2 mice per concentration to establish the highest concentration of test substance which did not lead to systemic toxicity or excessive local irritation. The results of preliminary investigations indicated that 50% w/v would be a suitable high concentration for use on the main study.
Main Study
Group dpm/node and Stimulation Index
Group |
Concentration |
dpm |
Number of lymph nodes per animal |
Dpm/node |
Stimulation index # |
Result + positive, - negative |
3 |
AOO |
357.10 |
8.0 |
44.64 |
n/a |
n/a |
4 |
10% w/v SABoTBA |
395.20 |
8.0 |
49.40 |
1.1 |
- |
5 |
25 w/v SABoTBA |
364.80 |
8.0 |
45.60 |
1.0 |
- |
6 |
50 w/v SABoTBA |
520.50 |
8.0 |
65.06 |
1.5 |
- |
7 |
HCA 25% v/v |
1985.10 |
8.0 |
248.14 |
5.6 |
+ |
# Stimulation Index of 3 or more indicates a positive result
dpm Disintegrations per minute less background count of 35.80
AOO Acetone:olive oil (4:1 v/v) (vehicle control)
HCA Hexyl cinnamic aldehyde (positive control)
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- SABoTBA is not regarded as a potential skin sensitizer.
- Executive summary:
The study was performed to assess the skin sensitization potential of SABoTBA using the local lymph node assay (LLNA) in accordance with OECD Guideline 429. Preliminary investigations were performed at 25 and 50% w/v with 2 mice per concentration to establish the highest concentration of test substance which did not lead to systemic toxicity or excessive local irritation. The results of preliminary investigations indicated that 50% w/v would be a suitable high concentration for use on the main study.
The study comprised three treated groups, each comprising four female mice receiving the test substance at concentrations of 10, 25 or 50% w/v. Similarly constituted groups received the vehicle Acetone: olive oil (4:1 v/v) or positive control substance (25% v/v hexyl cinnamic aldehyde). The mice were treated by daily application of 25 µL of the appropriate concentration or control (vehicle or positive), to the dorsal surface of both ears for three consecutive days.
The proliferative response of the lymph node cells (LNC) from the draining auricular lymph nodes was assessed five days following the initial application, by measurement of the incorporation of 3H-methyl Thymidine (3HTdR) by β-scintillation counting of LNC suspensions. The response was expressed as radioactive disintegrations per minute per lymph node (dpm/node) and as the ratio of 3HTdR incorporation into LNC of test nodes relative to that recorded for control nodes (test/control ratio), termed as Stimulation Index (SI).
The test substance is regarded as a sensitizer if at least one concentration of the chemical has a SI of three or more.
Results
The SI obtained for 10, 25 and 50% w/v were 1.1, 1.0 and 1.5 respectively which indicates that SABoTBA did not show the potential to induce skin sensitization.
The SI for the positive control substance hexyl cinnamic aldehyde was 5.6, which demonstrates the validity of this study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.